Canopy Growth Corporation(WEED-T)
TSX

Today's Change
Real-Time Last Update
Day Low1.35
Day High1.41
Open:1.37
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
Stocks in play: Canopy Growth Corporation
Canopy Growth Reports First Quarter Fiscal Year 2027 Financial Results; Delivers 13% Net Revenue Growth with Contributions from All Businesses
Stocks in play: Canopy Growth Corporation
Canopy Growth to Report First Quarter Fiscal 2027 Financial Results on August 7, 2026
Canopy Growth Announces Participation at Upcoming Canaccord Genuity Growth Conference
Upcoming Meeting Dates - July 13, 2026
Canopy Growth Reports Fourth Quarter and Fiscal Year 2026 Financial Results; Delivers Q4 FY2026 Net Revenue Growth of 27% in Canada Medical and 68% in International Markets Cannabis
Canopy Growth Announces Claybourne’s Frosted Flyers Wins ‘Best Infused Pre-Roll' at 2026 Grow Up Awards
Canopy Growth Relaunches Tweed Brand in Germany with New MTL Cannabis Strain Lineup, Marking First International Release following Acquisition
Canopy Growth Provides Update on Financial Reporting and Announces Fourth Quarter and Fiscal Year 2026 Financial Results to be Presented on June 15, 2026
Europe’s Cannabis Boom Is Accelerating as Billions Flow into Licensed Markets
Stocks in play: Canopy Growth Corporation
Canopy Growth and Spectrum Therapeutics Expand Medical Portfolio with New 30 and 90-Pack Softgels and Enhanced Dosing Options
Stocks in play: Canopy Growth Corporation
‘There’s a Tweed for That’: Canopy Growth Announces Tweed Brand Summer Campaign

Profile

Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.